Virtus Biotech Clinical Trials ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.79
資產淨值: 42.98
成立日期: 16/12/2014
 
分析
市值分佈:
27.79%
大市值
37.89%
中市值
34.65%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/11/2026 05:47) 總持有投資項目: 132  
0%
 
100%
     10大 (16.14%)
代號 名稱 佔比% ▼ 持有日期
ORICOric Pharmaceuticals0.8730/10/2026
EWTXEdgewise Therapeutics0.8730/10/2026
CGONCG Oncology0.8630/09/2026
IDYAIDEAYA Biosciences0.8630/10/2026
CGEMCullinan Therapeutics0.8530/10/2026
PHVSPharvaris NV0.8530/10/2026
PRAXPraxis Precision Medicines0.8330/10/2026
RGNXREGENXBIO0.8230/09/2026
ANROAlto Neuroscience0.8230/10/2026
ARVNArvinas0.8030/10/2026
DMRADamora Therapeutics, Inc.0.8030/10/2026
PRTAProthena Corp0.8030/10/2026
ERASErasca0.7930/10/2026
SRRKScholar Rock Holding Corp0.7930/09/2026
DNTHDianthus Therapeutics0.7830/09/2026
IMNMImmunome0.7730/10/2026
MGTXMeiraGTx Holdings plc0.7730/10/2026
ABUSArbutus Biopharma Corp0.7730/10/2026
GHRSGH Research PLC0.7730/10/2026
RZLTRezolute0.7730/10/2026
  1    2   3    4    5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.